CSBR insider trading
NasdaqCM HealthcareCHAMPIONS ONCOLOGY, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About CHAMPIONS ONCOLOGY, INC.
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Company website: www.championsoncology.com
CSBR insider activity at a glance
FilingIQ has scored 222 insider transactions for CSBR since Dec 1, 2014. The most recent filing in our index is dated Nov 5, 2025.
Across the full history, 80 open-market purchases
and 6 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CSBR insider trades is 53.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Top insiders trading CSBR
Frequently asked
- How many insider trades does FilingIQ track for CSBR?
- FilingIQ tracks 222 Form 4 insider transactions for CSBR (CHAMPIONS ONCOLOGY, INC.), covering filings from Dec 1, 2014 onwards. 0 of those were filed in the last 90 days.
- Are CSBR insiders net buyers or net sellers?
- Across the full Form 4 history for CSBR, 80 transactions (36%) were open-market purchases and 6 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CSBR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is CSBR in?
- CHAMPIONS ONCOLOGY, INC. (CSBR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $83.18M.
Methodology & sources
Every CSBR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.